Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Chemcel Biotech Ltd (533026)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533026 NSE: Pesticides & Agrochemicals | Small Cap | Chemcel Biotech Share Price
BSE Share Price
Not Listed
Not Listed
Chemcel Biotech Ltd (533026)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 533026 NSE: Pesticides & Agrochemicals | Small Cap | Chemcel Biotech Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹3 Cr.
Current Price
₹0
52-Week Low / High
₹1 / 1
TTM EPS
₹0.1
TTM Sales
₹41.1 Cr.
Book Value per Share
₹15.6
P/E Ratio
18.68
Industry PE
26.8
Price to Book (P/B)
0.06
Price to Sales (P/S)
0.06
EV/EBITDA
6.23
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
2.07%
Return on Capital Employed (ROCE)
4.62%
Return on Assets (ROA)
1.46%
Operating Profit Margin
4.9%
Net Profit Margin
1.69%
Gross Profit Margin
2.4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
9.62%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-15.81%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
-37.04%
Asset Quality
Promoter Holding
20.01%
Pledged shares (%) of Promoter's holding (%)
76.06%
Reserves
₹16 Cr.
Equity
₹27.9 Cr.
Face Value
₹10
All Time Low / High
₹0.95 / 16.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 9% | 15.6% | 15% | 13.7% | 14.4% | 9.4% | 6.2% | 4.7% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 12.8 | 12.9 | 21.4 | 23.3 | 24.6 | 35.2 | 45.8 | 50.2 | 41 |
| Sales YoY Gr. | - | NA | NA | 0.6% | 65.5% | 9.2% | 5.3% | 43.2% | 30% | 9.6% | - |
| Adj EPS ⓘ | 0 | 0 | 1.2 | 2.6 | 1.1 | 0.9 | 1.2 | 0.5 | 0.5 | 0.3 | 0.1 |
| YoY Gr. | - | NA | NA | 118% | -57.3% | -18.4% | 34.8% | -57.5% | 3.9% | -41.5% | - |
| BVPS (₹) ⓘ | 0 | 0 | 10.8 | 11 | 10.7 | 11.5 | 12.6 | 14.6 | 15.3 | 15.3 | 15.6 |
| Adj Net Profit ⓘ | 0 | 0 | 0.1 | 0.2 | 0.7 | 0.9 | 1.3 | 1.3 | 1.4 | 0.9 | 0 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 0.6 | -1.4 | -5.7 | -6.5 | -0.1 | -14.1 | -5 | -3.8 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 3.4 | -2.6 | -0.8 | -1 | -53.2 | -0.4 | -1.9 | -2.7 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 18.6% | 26.8% | 9.6% | ||||
| Adj EPS ⓘ | NA | -22.2% | -36.3% | -41.5% | ||||
| BVPSⓘ | NA | 7.5% | 6.6% | 0.2% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 7.8 | 10.4 | 15.1 | 9.8 | 9.9 | 5 | 3.4 | 2 | 0.4 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 3.3 | 6.5 | 6.4 | 9.3 | 11.8 | 8.7 | 6.4 | 4.9 | 5 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0.7 | 1.4 | 3.4 | 4 | 5.1 | 3.7 | 3 | 1.7 | 0.4 |
| Debt to Equity ⓘ | 0 | 0 | 2.5 | 4.5 | 0.7 | 0.5 | 0.5 | 0.1 | 0.2 | 0.2 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 180 | 166 | 284 | 376 | 326 | 326 | 348 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 110 | 93 | 110 | 124 | 177 | 201 | 221 | 0 |
Valuation of Chemcel Biotech - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 18.37 | 0.00 | 0.00 | 37.63 | 37.75 | 37.75 | 37.75 | 64.84 | 74.72 | 76.06 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'08 | Mar'09 | Mar'10 | Mar'11 |
|---|---|---|---|---|
| Sales | 24.58 | 35.19 | 45.76 | 50.16 |
| Operating Expenses ⓘ + | 21.69 | 32.16 | 42.86 | 47.71 |
| Operating Profit ⓘ | 2.88 | 3.03 | 2.91 | 2.45 |
| Operating Profit Margin (%) | 11.7% | 8.6% | 6.4% | 4.9% |
| Other Income ⓘ + | 0 | 0 | 0 | 0 |
| Interest ⓘ | 1.15 | 1.20 | 1.06 | 1.24 |
| Depreciation ⓘ | 0.11 | 0.10 | 0.09 | 0.08 |
| Profit Before Tax ⓘ | 1.63 | 1.73 | 1.76 | 1.13 |
| Tax ⓘ | 0.39 | 0.44 | 0.41 | 0.28 |
| Profit After Tax | 1.24 | 1.29 | 1.35 | 0.85 |
| PAT Margin (%) | 5.1% | 3.7% | 2.9% | 1.7% |
| Adjusted EPS (₹) | 1.2 | 0.5 | 0.5 | 0.3 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'08 | Mar'09 | Mar'10 | Mar'11 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 13.29 | 39.02 | 40.53 | 43.37 | |||||||
| Debt + | 7.02 | 5.05 | 9.59 | 10.07 | |||||||
| Minority Interest | 0.01 | 0 | 0 | 0 | |||||||
| Trade Payables | 3.35 | 1.05 | 3.23 | 1.45 | |||||||
| Others Liabilities ⓘ | 4.64 | 2.04 | 2.50 | 5.19 | |||||||
| Total Liabilities ⓘ | 28.31 | 47.17 | 55.85 | 60.08 | |||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 1.29 | 1.23 | 1.15 | 1.07 | |||||||
| CWIP ⓘ | 0 | 7.37 | 7.37 | 7.37 | |||||||
| Investments ⓘ | 0 | 0 | 0 | 0 | |||||||
| Inventories | 1.35 | 3.33 | 4.94 | 5.41 | |||||||
| Trade Receivables | 11.26 | 23.85 | 24.22 | 32.40 | |||||||
| Cash Equivalents | 0.14 | 0.07 | 0.03 | 0 | |||||||
| Others Assets ⓘ | 14.26 | 11.32 | 18.14 | 13.82 | |||||||
| Total Assets ⓘ | 28.31 | 47.17 | 55.85 | 60.08 | |||||||
| PARTICULARS | Mar'08 | Mar'09 | Mar'10 | Mar'11 |
|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 6.08 | -14.08 | -4.98 | -3.77 |
| Cash Flow From Investing Activity ⓘ + | 0.57 | -8.66 | 0.25 | 0.26 |
| Cash Flow From Financing Activity ⓘ + | -6.52 | 22.67 | 4.69 | 3.48 |
| Net Cash Flow ⓘ | 0.13 | -0.07 | -0.04 | -0.03 |
| PARTICULARS | Mar'08 | Mar'09 | Mar'10 | Mar'11 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 9.35 | 5.05 | 3.49 | 2.07 | ||||||
| ROCE (%) | 13.69 | 9.28 | 6.14 | 4.62 | ||||||
| Asset Turnover Ratio | 0.87 | 0.95 | 0.91 | 0.88 | ||||||
| PAT to CFO Conversion(x) | 4.9 | -10.91 | -3.69 | -4.44 | ||||||
| Working Capital Days | ||||||||||
| Receivable Days | 167.20 | 178.70 | 187.80 | 202.70 | ||||||
| Inventory Days | 20.10 | 23.80 | 32.30 | 37 | ||||||
| Payable Days | 0 | 29.40 | 20.20 | 18.90 | ||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Chemcel Biotech Ltd FAQs
The current trading price of Chemcel Biotech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Chemcel Biotech stood at ₹2.65 Cr
The latest P/E ratio of Chemcel Biotech as of 31-Dec-1969 is 15.98.
The latest P/B ratio of Chemcel Biotech as of 31-Dec-1969 is 0.06.
The 52-week high of Chemcel Biotech is ₹0.95 and the 52-week low is ₹0.95.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemcel Biotech is ₹41.09 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Chemcel Biotech Ltd
Chemcel Biotech was originally incorporated as ‘Chemcel Products Limited’ on September 29, 1995 under the Companies Act, 1956 in the State of Andhra Pradesh, India. The name of the Company was changed to Chemcel Bio-Tech Limited with effect fro January 4, 2001.
Chemcel Biotech Ltd was incorporated with the main objective of manufacturing of Agro Chemicals. Later on it started producing bio-fertilisers and bio-pesticides also. In order to reflect this activity, the company changed its name as Chemcel Biotech Limited, with effect from January 04, 2001.
It is a premium manufacturer of agro chemicals comprising of insecticides, Fungicides and plant growth promoters. The unit' s registered office & factory are located in JRD Tata Industrial Estate, Vijayawada.
The company has been promoted by K.Bala Krishna Rao, K.T.Vijay Kumar & KCS Prasad. All these promoters have earlier worked with some of the leading agrochemicals/pesticides manufacturing companies in various capacities and have rich experience in this industry.
The company’s Registered office and factory are located at Tata Industrial estate, Kanuru, Vijayawada, their own premises. The total area of the plot of land is about 1849.02 sq.yards. It has two RCC buildings with 3 floors in each building constructed on the plot. The company has all the necessary plant & machinery & other infrastructure to attain a turnover of Rs.60.00 Crores.
The company already imported pilot plant from U.K-“Mark and Simon Associates†to manufacture Bio-diesel.
Product range of the company includes:
- Hexa
- Cosy
- Counter
- Celphate
- Monocel
- Chase
- Bumper
- Cythrin
- Care Quintox
- Cheminocel SP Lead
- Cheminocel SL
- Cordite
Achievements/ recognition:
- Awarded as best Industry. Chemcel Biotech Limited (CBL) is the winner of the Best Entrepreneur award from JRD Tata Industrial Estate, Vijaywada.
- Chemcel Biotech Limited (CBL) is the winner of the Best Entrepreneur award from JRD Tata Industrial Estate, Vijaywada.
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
